Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Grabbert

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Urologia Internationalis|January 31, 2021
Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic FactorsJan-Niclas Mumm, Benedikt Klehr, Severin Rodler, et al.
International Journal of Surgery (London, England)|April 19, 2017
Registry of implants for the reconstruction of pelvic floor in males and females: A feasibility case seriesDimitri Barski, Holger Gerullis, Thorsten Ecke, et al.
Neurourology and Urodynamics|March 4, 2020
Retropubic vs transobturator Argus adjustable male sling: Results from a multicenter studyHagen Loertzer, Tanja Huesch, Ruth Kirschner-Hermanns, et al.
World Journal of Urology|May 9, 2024
Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized studyJakob Michaelis, Max Träger, Sophie Astheimer, et al.
Cells|July 14, 2023
A YAP/TAZ-ARHGAP29-RhoA Signaling Axis Regulates Podocyte Protrusions and Integrin AdhesionsManuel Rogg, Jasmin I Maier, Martin Helmstädter, et al.
Journal of Clinical Medicine|June 28, 2023
Is the Standard Artificial Urinary Sphincter AMS 800 Still a Treatment Option for the Irradiated Male Patient Presenting with a Devastated Bladder Outlet?Fabian Queissert, Tanja Huesch, Alexander Kretschmer, et al.
Urologia Internationalis|September 13, 2021
Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational SurveyJulian P Struck, Martin J P Hennig, Marie C Hupe, et al.
Science Advances|November 28, 2025
Arp2/3-dependent regulation of ciliogenesis governs adaptive distal tubular epithelial cell states in kidney diseaseManuel Rogg, Lisa Weißer, Jasmin I Maier, et al.
The Journal of Pathology|November 25, 2024
Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartmentThien-Ly Julia Dinh, Manuel Rogg, Miguel Cosenza-Contreras, et al.
The Oncologist|February 23, 2024
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMISNeal D Shore, Christian Gratzke, Susan Feyerabend, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Urologia Internationalis|January 31, 2021
Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic FactorsJan-Niclas Mumm, Benedikt Klehr, Severin Rodler, et al.
International Journal of Surgery (London, England)|April 19, 2017
Registry of implants for the reconstruction of pelvic floor in males and females: A feasibility case seriesDimitri Barski, Holger Gerullis, Thorsten Ecke, et al.
Neurourology and Urodynamics|March 4, 2020
Retropubic vs transobturator Argus adjustable male sling: Results from a multicenter studyHagen Loertzer, Tanja Huesch, Ruth Kirschner-Hermanns, et al.
World Journal of Urology|May 9, 2024
Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized studyJakob Michaelis, Max Träger, Sophie Astheimer, et al.
Cells|July 14, 2023
A YAP/TAZ-ARHGAP29-RhoA Signaling Axis Regulates Podocyte Protrusions and Integrin AdhesionsManuel Rogg, Jasmin I Maier, Martin Helmstädter, et al.
Journal of Clinical Medicine|June 28, 2023
Is the Standard Artificial Urinary Sphincter AMS 800 Still a Treatment Option for the Irradiated Male Patient Presenting with a Devastated Bladder Outlet?Fabian Queissert, Tanja Huesch, Alexander Kretschmer, et al.
Urologia Internationalis|September 13, 2021
Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational SurveyJulian P Struck, Martin J P Hennig, Marie C Hupe, et al.
Science Advances|November 28, 2025
Arp2/3-dependent regulation of ciliogenesis governs adaptive distal tubular epithelial cell states in kidney diseaseManuel Rogg, Lisa Weißer, Jasmin I Maier, et al.
The Journal of Pathology|November 25, 2024
Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartmentThien-Ly Julia Dinh, Manuel Rogg, Miguel Cosenza-Contreras, et al.
The Oncologist|February 23, 2024
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMISNeal D Shore, Christian Gratzke, Susan Feyerabend, et al.
Pageof 7